Kymera Therapeutics Appoints Felix J. Baker, Ph.D., as Chairman of the Board of Directors Life Science Investing
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
The Radoff-JEC Group Urges Seer, Inc. Stockholders to Vote for Boardroom Change Today Life Science Investing
TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference Life Science Investing
Agility Robotics to Go Public Through $2.5 Billion Merger with Churchill Capital Corp XI Life Science Investing
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® Life Science Investing
ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics Life Science Investing
Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling Life Science Investing
Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors Life Science Investing
